Penn Medicine Provider
Dermatology
Misha Rosenbach, MD
5.0
(297)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Vice Chair, Education
  • Director, Cutaneous Sarcoidosis & Granulomatous Disease Clinic
  • Dermatology Residency Program Director
  • Paul R. Gross Professor of Dermatology
  • Professor of Dermatology in Medicine (Rheumatology)

Education and training

  • Medical School: NewYork-Presbyterian / Weill Cornell Medical Center
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

297 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
outstanding care!
May 2025
5.0
5.0
mastery of his field, incredibly knowledgeable
May 2025
5.0
5.0
he provides excellent care and he takes his time with you to explain everything
May 2025
5.0
5.0
addressed all of my concerns and provided action where needed.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Rosenbach is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Rosenbach, M. "Climate change and dermatology" , Skin To It podcast: 2025

Niebel D, Tso S, Parker ER, Rosenbach M, Tan E, Thio HB, Coates S, Andersen LK, Wolstencroft PW, Hecker C, Saha S, de Berker D. Environmental impact of dermatology and action towards it: a narrative review. , Int J Dermatol: 2025, https://doi.org/10.1111/ijd.17810

Junejo MH, Hwang E, Rufin O, Shields BE, Rosenbach M, Wang Y, King B, Damsky W. JAK1 inhibition is sufficient for the treatment of granuloma annulare. , J. Invest Dermatology: 2025,In Press

Ebriani J, Santiago-Soltero K, Anshelevich EE, Dalal RS, Shields B, Charrow A, Agrawal M, Alvavi A, Burgin S, Cices A, Coromilas AJ, Cowen EW, Goldfarb N, Hsiao JL, McGee JS, Ortega-Loayza AG, Porter M, Rosenbach M, Shaw KS, Wanat KA, Watson AJ, Wong SY. Delphi panel for the development of diagnostic criteria for metastatic cutaneous Crohn disease: a consensus statement. , JAMA Dermatology: 2025

Silva GS, Waegel A, Kepner J, Evans G, Braham W, Rosenbach M. Carbon footprint analysis of an outpatient dermatology practice at an academic medical center. , JAMA Dermatol: 2025,epub (ahead of print)

Rubenstein A, Chung J, Rosenbach M. Granuloma annulare treated with certolizumab following the development of anti-drug antibodies to adalimumab. , JAAD Case Rep, In Press: 2025

Tan E, Niebel D, Rosenbach M Carbon footprint analyses: a valuable tool for dermatology j9orunals to pioneer sustainable practices. , J Eur Acad Dermatol Venereol, In Press: 2025

Parker ER, Rosenbach M, Davis MDP The American Dermatological Association's 2025 official policy statement on climate change: a bold commitment toward health equity and sustainability. , Arch Dermatol Res, 317: 2025,480

Parker ER, Rosenbach M Southern Tick-Associated Rash illness , N Engl J Med., 392(16): 2025,1636

Valdes Moraeles KL, Bornstein M, Hannah CE, Vazquez T, Rauck C, Elenitsas RE, Ammazzalorso A, Sahrish I, Weikert BC, Baumrin E, Sivendran M, Forrestel A, Rosenbach M. Cytomegalovirus anogenital ulcers in a patient with HIV , JAAD Case Reports, In Press: 2025